Newly released Medicare national coverage determinations are set to reshape the home ventilation landscape for chronic ...

Continuous positive airway pressure (CPAP) has a greater effect on sleepiness and quality of life in younger vs older patients with OSA.

Both continuous positive airway pressure (CPAP) and tirzepatide are acceptable treatments for comorbid obesity and obstructive sleep apnea (COBOSA), with providers favoring CPAP and patients ...

Australia's Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnea, a condition ...

SEATTLE -- Weight loss drugs have gained momentum as treatment for obstructive sleep apnea (OSA) at sleep clinics across the ...

Thousands to benefit as weight loss drug Mounjaro approved for new use - Australia and the United States have both approved ...

Last week, Australia’s Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnoea, a condition in which breathing stops and starts repeatedly during sleep.

AirSnore’s combination of a clinically proven mandibular advancement device and a unique blend of natural, science-backed ...

Guggenheim Partners called Insmed’s Phase IIb readout “impressive across the board,” with an efficacy profile that positions ...

A clash is brewing between doctors and patients when it comes to treatment for sleep apnea in those with obesity, a new study ...

SAN FRANCISCO, May 6, 2025 /PRNewswire/ -- The global continuous positive airway pressure devices market size is anticipated to reach USD 2.62 billion by 2030, growing at a CAGR of 5.45% during ...

Objectives: To study whether nasal continuous positive airway pressure (nCPAP) improves pulmonary oxygen transfer and avoids reintubation in patients with severe nonhypercapnic oxygenation failure ...